News

Announcing a new article publication for Cardiovascular Innovations and Applications journal. This article aimed to identify ...
Europe’s Committee for Medicinal Products for Human Use (CHMP) has recommended granting a conditional marketing authorization for Duvyzat (givinostat, Italfarmaco) to treat Duchenne muscular ...